Search Results 1011-1020 of 17580 for Assay

1. The ExTINGUISH Trial Of Inebilizumab In NMDAR Encephalitis (ExTINGUISH) - Mayo Clinic

   A positive cell-based assay for anti-NMDA receptor IgG antibody in the CSF confirmed in study-specified laboratories. Age ≥ 18 years. Written informed ...

2. Understanding the role of gut microbiome in pathogenesis of Clostridioides difficile infection

   The lab also uses novel in vitro and ex vivo assays, including microfluidic devices and organoids. Germ-free mice colonized with patient-derived microbiota ...

3. Alzheimer's Disease Clinical Trials - Mayo Clinic Research

   The purpose of this study is to validate the Alzheimer Disease Biomarkers assays (Phospho-Tau/Total-Tau/Ab42) being implemented at Mayo to compare them to the ...

4. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

   Note: Patients are not evaluable by CA 125 if they have received mouse antibodies (unless the assay used has been shown not to be influenced by human anti ...

5. A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer - Mayo Clinic

   Patients with a negative polymerase chain reaction (PCR) assay are permitted with appropriate antiviral prophylaxis. Active hepatitis C infection or known ...

6. A Study of TNB-383B in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Serum free light chain (FLC) assay: Involved FLC level ≥ 10 mg/dl (≥ 100 mg/L) and an abnormal serum FLC ratio (< 0.26 or > 1.65). Subject has confirmed ...

7. Skin Cancer Clinical Trials - Mayo Clinic Research

   The primary objective of this collaborative study is to collect biospecimens for the evaluation of internally developed assays designed to predict for and ...

8. Study to Evaluate the Effectiveness and Safety of Remdesivir in Participants with Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 - Mayo Clinic

   ... assay (e.g., Nucleic Acid Amplification Test [NAAT] and antigen tests) in any respiratory specimen. Hospitalized for COVID-19. Age ≥ 12 years and weighing ...

9. Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers - Mayo Clinic

   ... assay; 4. Failed or been intolerant of prior lines of systemic therapy; 5. Estimated life expectancy > 4 months; 6. At least 1 measurable lesion per RECIST ...

10. ACTIV-5 / Big Effect Trial (BET-B) for the Treatment of COVID-19 - Mayo Clinic

    ... assay (e.g., Nucleic Acid Amplification Test [NAAT], antigen test) in any respiratory specimen, or saliva 5 times the upper limit of normal. Illness of any ...